Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs ...
Xevant, a leader in pharmacy benefits analytics, today announced the release of a new white paper: "Cracking Open the PBM Black Box: Unlocking Transparency and Partnership with VerX." The report ...
KFF Health News on MSN
Off-Label Drug Helps One Boy With Autism Speak, Parents Say. But Experts Want More Data.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback